Literature DB >> 1711544

Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors.

Y Nagayama1, H L Wadsworth, D Russo, G D Chazenbalk, B Rapoport.   

Abstract

We examined the relative effects of thyrotropin (TSH) and TSH receptor autoantibodies in the sera of patients with autoimmune thyroid disease on three TSH-lutropin/chorionic gonadotropin (LH/CG) receptor extracellular domain chimeras. Each chimera binds TSH with high affinity. Only the chimera with TSH receptor extracellular domains ABC (amino acids 1-260) had a functional (cAMP) response to thyroid stimulatory IgG. The chimeras with TSH receptor domains CD (amino acids 171-360) and DE (amino acids 261-418) were unresponsive. The lack of response of the chimera with TSH receptor domains DE was anticipated because it fails to transduce a signal with TSH stimulation, unlike the other two chimeras. A different spectrum of responses occurred when the TSH-LH/CG chimeras were examined in terms of autoantibody competition for TSH binding. IgG with TSH binding-inhibitory activity when tested with the wild-type TSH receptor also inhibited TSH binding to the chimera with TSH receptor domains DE. Dramatically, however, these IgG did not inhibit TSH binding to the chimera with TSH receptor domains CD, and had weak or absent activity with the chimera with TSH receptor domains ABC. Chimeras with TSH receptor domains ABC and DE were equally effective in affinity-purifying IgG with thyroid-stimulatory and TSH binding-inhibitory activities. Nonstimulatory IgG with TSH binding-inhibitory activity inhibited the action of stimulatory IgG on the wild-type TSH receptor, but not with the chimera containing TSH receptor domains ABC. In summary, TSH receptor autoantibodies and TSH bind to regions in both domains ABC and DE of the TSH receptor extracellular region. Stimulatory and inhibitory TSH receptor autoantibodies, as well as TSH, appear to bind to different sites in domains ABC, but similar sites in domains DE, of the receptor. Alternatively, TSH and the different TSH receptor antibodies bind with differing affinities to the same site in the ABC region.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711544      PMCID: PMC296038          DOI: 10.1172/JCI115297

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain.

Authors:  H Loosfelt; M Misrahi; M Atger; R Salesse; M T Vu Hai-Luu Thi; A Jolivet; A Guiochon-Mantel; S Sar; B Jallal; J Garnier
Journal:  Science       Date:  1989-08-04       Impact factor: 47.728

2.  Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family.

Authors:  K C McFarland; R Sprengel; H S Phillips; M Köhler; N Rosemblit; K Nikolics; D L Segaloff; P H Seeburg
Journal:  Science       Date:  1989-08-04       Impact factor: 47.728

3.  Thyroid-stimulating immunoglobulins in Graves' disease.

Authors:  B R Smith; R Hall
Journal:  Lancet       Date:  1974-08-24       Impact factor: 79.321

4.  Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding.

Authors:  Y Nagayama; D Russo; G D Chazenbalk; H L Wadsworth; B Rapoport
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

5.  The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA.

Authors:  R Sprengel; T Braun; K Nikolics; D L Segaloff; P H Seeburg
Journal:  Mol Endocrinol       Date:  1990-04

6.  Isolation of TSH and LH/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing.

Authors:  A L Frazier; L S Robbins; P J Stork; R Sprengel; D L Segaloff; R D Cone
Journal:  Mol Endocrinol       Date:  1990-08

7.  Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding site.

Authors:  T Piraphatdist; H Sugawa; D Inoue; T Enomoto; T Mori; H Imura
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

8.  Interactions between TSH binding inhibiting--and adenylate cyclase stimulating--antibodies in Graves' disease.

Authors:  S Morita; M Izumi; S Nagataki
Journal:  Acta Endocrinol (Copenh)       Date:  1986-08

9.  A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol.

Authors:  K Kasagi; J Konishi; K Arai; T Misaki; Y Iida; K Endo; K Torizuka
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

10.  Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.

Authors:  Y Nagayama; H L Wadsworth; G D Chazenbalk; D Russo; P Seto; B Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more
  14 in total

1.  Thyroid autoimmunity.

Authors:  B Rapoport; S M McLachlan
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Thyroid       Date:  2013-01       Impact factor: 6.568

Review 3.  Immunity to the thyroid-stimulating hormone receptor.

Authors:  J Furmaniak; B R Smith
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Statistical analysis of functional region(s) of the TSH receptor.

Authors:  H Sugawa; Y Ueda; T Akamizu; S Kosugi; J Okuda; C Ohta; Y Kiho; T Mori
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

5.  The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.

Authors:  Larissa Seifert; Elion Hoxha; Anna M Eichhoff; Gunther Zahner; Silke Dehde; Linda Reinhard; Friedrich Koch-Nolte; Rolf A K Stahl; Nicola M Tomas
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

6.  Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.

Authors:  Gregorio D Chazenbalk; Pavel Pichurin; Chun-Rong Chen; Francesco Latrofa; Alan P Johnstone; Sandra M McLachlan; Basil Rapoport
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 7.  Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

Authors:  Terry F Davies; Takao Ando; Reigh-Yi Lin; Yaron Tomer; Rauf Latif
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  Characterization of the murine immune response to the murine TSH receptor ectodomain: induction of hypothyroidism and TSH receptor antibodies.

Authors:  H Vlase; M Weiss; P N Graves; T F Davies
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

9.  T cell responses to synthetic TSH receptor peptides in Graves' disease.

Authors:  N Tandon; M A Freeman; A P Weetman
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

10.  Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor.

Authors:  W B Minich; C Lenzner; N G Morgenthaler
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.